Family Connections

June 25, 2025 updated by: Katherine Grimes MD, Cambridge Health Alliance

Family Connections: A Community-Based Approach to Expanding Mental Health Access and Engagement for SED Youth

The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Massachusetts
      • Cambridge, Massachusetts, United States, 02139
        • Recruiting
        • Cambridge Health Alliance
        • Contact:
          • Katherine Grimes, Md, MPH
          • Phone Number: 857-523-8398

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 3 through 18 years (17½ years maximum at time of enrollment)
  • Referred by Primary Care Physician's (PCP) from one of the three Cambridge Health Alliance (CHA) primary care intervention sites to the Family Connections team for an integrated child mental health and/or substance use disorder clinical assessment.
  • Positive screen on CHA's standard pediatric mental health and substance use screening instruments, and/or parental concern about possible mental health/substance use needs, and/or PCP concern about possible mental health/substance use needs
  • Enrolled in MassHealth

Exclusion Criteria:

  • Subjects over 17.5 years (SAMHSA data collection required at 6 and 12 months after enrollment which must occur before age 18 years.)
  • Youth who are not enrolled in MassHealth
  • CHA patients with PCP located at CHA primary care site other than the identified intervention sites

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment as Usual
Active Comparator: Active Comparator: Family Connections Intervention
"Family Connections" Care Planning Team: Clinical expertise will be combined with peer-to-peer parent/guardian support for trauma-informed care delivery to both parent and child. All aspects of the care continuum will be provided in a culturally and linguistically competent manner, with child and family-driven care planning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Child and Adolescent Functional Assessment Scale (CAFAS) Score
Time Frame: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

Comparative analysis of baseline and follow-up clinical functioning scores

CAFAS Scoring:

Levels of Dysfunction None or minimal 0-10 Mild 20-30 Moderate 40-60 Marked 70-80 Severe >90

Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months
Changes in Children's Global Assessment Scale (CGAS) Score
Time Frame: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

Comparative analysis of baseline and follow-up clinical functioning scores

CGAS Scale:

100-91 Superior functioning 90-81 Good functioning 80-71 No more than a slight impairment in functioning 70-61 Some difficulty in a single area, but generally functioning pretty well 60-51 Variable functioning with sporadic difficulties 50-41 Moderate degree of interference in functioning 40-31 Major impairment to functioning in several areas 30-21 Unable to function in almost all areas 20-11 Needs considerable supervision 10-1 Needs constant supervision

Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months
Family perceptions of care using the Family Professional Partnership Scale (FPPS).
Time Frame: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

Analysis of baseline and follow-up family perceptions of care (18 Questions):

  1. - Very Dissatisfied
  2. - Dissatisfied
  3. - Neither
  4. - Satisfied
  5. - Very Satisfied
Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months
Access to child mental health and substance abuse (MH/SA) care
Time Frame: 0-6 months
Comparative analysis of access to care trends
0-6 months
Engagement in child mental health and substance abuse (MH/SA) treatment
Time Frame: 6-12 months
Comparative analysis of service use trends
6-12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine E Grimes, MD, MPH, Cambridge Health Alliance

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2025

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

September 29, 2028

Study Registration Dates

First Submitted

October 25, 2024

First Submitted That Met QC Criteria

October 25, 2024

First Posted (Actual)

October 28, 2024

Study Record Updates

Last Update Posted (Actual)

June 26, 2025

Last Update Submitted That Met QC Criteria

June 25, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • H79SM089682 (Other Grant/Funding Number: SAMHSA)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotional Disturbance

Clinical Trials on Behavioral Treatment

Subscribe